Clinical Study
RyR2 QQ2958 Genotype and Risk of Malignant Ventricular Arrhythmias
Table 5
Genotypic frequency of RyR2 Q2958R in the study population subgroups according to arrhythmias occurrence.
| | Group I | Group II | value |
| Hypertensive patients () | | | | QQ | 12 (24.0%) | 0 (0%) | 0.0001 | QR | 37 (74.0%) | 56 (98.2%) | RR | 1 (2.0%) | 1 (1.8%) | Not hypertensive patients () | | | | QQ | 2 (4.3%) | 3 (4.2%) | 1 | QR | 43 (93.5%) | 68 (94.4%) | RR | 1 (2.2%) | 1 (1.4%) | Dyslipidemic patients () | | | | QQ | 5 (11.9%) | 6 (11.1%) | 1 | QR | 36 (85.7%) | 47 (87.0%) | RR | 1 (2.4%) | 1 (1.9%) | Not dyslipidemic patients () | | | | QQ | 4 (7.4%) | 3 (4.0%) | 0.6777 | QR | 49 (90.8%) | 71 (94.7%) | RR | 1 (1.8%) | 1 (1.3%) | Diabetic patients () | | | | QQ | 6 (15.0%) | 2 (4.0%) | 0.0696 | QR | 33 (82.5%) | 48 (96.0%) | RR | 1 (2.5%) | 0 (0%) | Not diabetic patients () | | | | QQ | 8 (14.3%) | 2 (2.5%) | 0.0204 | QR | 47 (83.9%) | 77 (95.0%) | RR | 1 (1.8%) | 2 (2.5%) |
|
|
with Fisher’s exact test, while using Armitage trend test.
|